Kyle Michael Wool Receives Stock Award at AIkido Pharma Inc (AIKI) — SEC Form 4, Aug 30, 2022
SEC Form 4 · No Market Transaction
Stock Award
Compensation grant — no market purchase or sale.
Equity Position
80.1K sh
1,470 → 80,058
Equity Change
+5346.1%
shares held after vs before
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Kyle Michael Wool CIK 0001856536 |
Director
CEO
|
Kyle Michael Wool at AIkido Pharma Inc
Full insider history
Bought (12 mo)
$209,190
Sold (12 mo)
$96,798
More from this insider at AIkido Pharma Inc
| 2026-09-14 | Buy | +$209,190 | View |
| 2026-03-25 | Award | — | View |
| 2025-12-10 | Sell | -$96,798 | View |
| 2025-04-16 | Award | — | View |
| 2025-03-25 | Award | — | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common StockF1 | 2022-08-26 | A - Award/Grant | 78,588 A | $6.00 | +$471,528 | 80,058 | Direct |
Footnotes (1)
- F1
- On August 26, 2022, the reporting person was granted 78,588 shares of restricted stock at $6.00 per share pursuant to the Company's 2014 Equity Incentive Plan (the "Plan"). Show more
Related filings at AIkido Pharma Inc
Institutional Holders
13F holders · Jun 30, 2026
30
institutional managers reporting a position
Largest by reported value
5%+ Holders · 13D/G
4 filers
-
Donald J. Trump Jr. 5.8%
-
Eric Trump 5.8%
-
Anthony Hayes 35.3%
-
Kyle Michael Wool 37.9%
Other insiders at AIkido Pharma Inc
GET /v1/forms/4/0001213900-22-052345
API docs
View Original SEC Filing